Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2016-05-10 Fund Information / Fact…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
105年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a brief summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data for April of 民國105年 (2016). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document length is only 765 characters, indicating it is a short summary rather than a full financial report. There is no indication of detailed financial statements, management discussion, or audit information. It is not an announcement of a report publication but a direct presentation of summarized financial data. Given the concise nature and content, this fits best as a Fund Information / Factsheet (FS) type, which is a brief summary of key company financials and market info.
2016-05-10 Chinese
105年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with zero balances and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or certification. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. The document length is very short (601 characters), and it does not qualify as a full financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2016-05-10 Chinese
105年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific data on stock types, holdings at appointment, monthly changes, and current holdings. The content focuses on insider share ownership and transactions, which aligns with reporting requirements for personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report publication announcement or a certification letter but a detailed insider shareholding disclosure. Therefore, the document fits the category of Director's Dealing (DIRS).
2016-05-04 Chinese
105年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It focuses on insider shareholdings and pledges, with no financial statements, earnings data, or meeting results. The content aligns with reporting of insider share transactions or holdings. Given the nature of the data and the focus on insider holdings, this fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is moderate and contains detailed insider shareholding data, not just an announcement or summary, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2016-05-04 Chinese
105年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific data on shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial results, report announcements, or other types of filings. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive, not just an announcement or certification.
2016-04-08 Chinese
105年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their current holdings, pledged shares, and related ratios. This type of disclosure is typical of insider share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or regulatory filings beyond insider shareholding data. Therefore, this document fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2016-04-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.